[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_1413 

# __Improved treatment guidelines__

## Articles mentionning this Benefit

* [Infodemic and the spread of fake news in the COVID-19-era](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_299.md)

## Stakeholders benefitting from this Benefit

* [patients](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_31.md)
* [medical professionals](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_425.md)

## Description of Benefits pertaining to Beneficiaries

* [Private investors would benefit from increased demand for evidence-based medication and potentially higher sales.](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_1604.md)

## Name of the Benefit

Provides reliable and scientifically proven information, guiding medical professionals in prescribing appropriate medications.

